- Home
- HDL vs STOK Comparison
HDL vs STOK Comparison
Compare HDL & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HDL
- STOK
- Stock Information
- Founded
- HDL 2016
- STOK 2014
- Country
- HDL Singapore
- STOK United States
- Employees
- HDL N/A
- STOK N/A
- Industry
- HDL Restaurants
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- HDL Consumer Discretionary
- STOK Health Care
- Exchange
- HDL Nasdaq
- STOK Nasdaq
- Market Cap
- HDL 1.1B
- STOK 1.3B
- IPO Year
- HDL 2024
- STOK 2019
- Fundamental
- Price
- HDL $17.81
- STOK $25.56
- Analyst Decision
- HDL
- STOK Strong Buy
- Analyst Count
- HDL 0
- STOK 6
- Target Price
- HDL N/A
- STOK $26.60
- AVG Volume (30 Days)
- HDL 3.1K
- STOK 1.1M
- Earning Date
- HDL 11-24-2025
- STOK 11-04-2025
- Dividend Yield
- HDL N/A
- STOK N/A
- EPS Growth
- HDL 197.81
- STOK N/A
- EPS
- HDL 0.09
- STOK 0.91
- Revenue
- HDL $805,433,000.00
- STOK $199,893,000.00
- Revenue This Year
- HDL $12.52
- STOK $416.54
- Revenue Next Year
- HDL $12.03
- STOK N/A
- P/E Ratio
- HDL $21.89
- STOK $28.15
- Revenue Growth
- HDL 9.65
- STOK 1218.82
- 52 Week Low
- HDL $15.54
- STOK $5.35
- 52 Week High
- HDL $30.00
- STOK $25.61
- Technical
- Relative Strength Index (RSI)
- HDL 34.79
- STOK 72.90
- Support Level
- HDL $17.99
- STOK $23.25
- Resistance Level
- HDL $19.16
- STOK $24.97
- Average True Range (ATR)
- HDL 0.25
- STOK 1.11
- MACD
- HDL -0.02
- STOK -0.05
- Stochastic Oscillator
- HDL 3.13
- STOK 98.66
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.